News

News

TSO3 to Report Third Quarter 2018 Results on Wednesday, November 7, 2018

TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, November 7, 2018 to discuss its financial results for the third quarter ended September 30, 2018.

TSO3’s President and CEO R.M. (Ric) Rumble and CFO Glen Kayll, will host the conference.

Read more

News

TSO3 Provides a Commercialization Update

Myrtle Beach, S.C. and Quebec City, Canada – October 4, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, provided an update regarding the Company’s commercialization of the Company’s STERIZONE® VP4 Sterilizer.  Readers are encouraged to visit the TSO3 website, www.tso3.com, to read the letter to shareholders posted on October 4, 2018, which outlines the Company’s progress to date and provides additional supporting information.

Read more

News

TSO3 Appoints Martin J. Madden to the Board of Directors

Myrtle Beach, S.C. and Quebec City, Canada – August 29, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has appointed Mr. Martin J. Madden to the Company’s board of directors.

Read more

News

UCHealth performs first patient procedure in Colorado using STERIZONE® technology

Loveland, Colo.; Myrtle Beach, S.C.; and Quebec City, Canada – August 20, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, joins with UCHealth, a nationally recognized, nonprofit network of 10 acute care hospitals and more than 150 clinics throughout Colorado, southern Wyoming and western Nebraska, in announcing the first patient procedure in Colorado performed with a duodenoscope sterilized using the STERIZONE® technology.

Read more

News

TSO3 Reports Second Quarter 2018 Results

Quebec City, Canada and Myrtle Beach, United States, – August 7, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for the second fiscal quarter ended June 30, 2018.

Read more